Hemophilia and Thrombosis Center/ University of Colorado Anschutz Medical Campus — Aurora, Colorado

Hemophilia and Thrombosis Center/ University of Colorado Anschutz Medical Campus is a clinical research site located in Aurora, Colorado, United States 80045.

Crixeo Health Trust Score: 57/100 (POOR). This profile has not yet been claimed by the site owner.

Hemophilia and Thrombosis Center/ University of Colorado Anschutz Medical Campus has participated in 1 clinical trials.

Therapeutic areas: Hemophilia A With Inhibitor, Haemophilia A Without Inhibitor, Hemophilia B With Inhibitor.

Sponsors: American Thrombosis and Hemostasis Network.

Sponsor Feasibility Report

Trust Score: 57/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Hemophilia and Thrombosis Center/ University of Colorado Anschutz Medical Campus?

Hemophilia and Thrombosis Center/ University of Colorado Anschutz Medical Campus has a Crixeo Trust Score of 57/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Hemophilia and Thrombosis Center/ University of Colorado Anschutz Medical Campus conducted?

Hemophilia and Thrombosis Center/ University of Colorado Anschutz Medical Campus has 1 clinical trials on record. Their work covers Hemophilia A With Inhibitor, Haemophilia A Without Inhibitor, Hemophilia B With Inhibitor.

Is Hemophilia and Thrombosis Center/ University of Colorado Anschutz Medical Campus accredited by Crixeo Health?

Hemophilia and Thrombosis Center/ University of Colorado Anschutz Medical Campus has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Hemophilia and Thrombosis Center/ University of Colorado Anschutz Medical Campus?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.